Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 67,346 shares at $8.13 ($542K) on 2021-08-02, disclosed to the SEC on 2021-08-04.
Open-market sale of $542k PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.13 | 6,570 | $53K | 9.9% |
| 2 | $8.13 | 6,570 | $53K | 9.9% |
| 3 | $8.13 | 7,167 | $58K | 10.8% |
| 4 | $8.13 | 7,167 | $58K | 10.8% |
| 5 | $7.99 | 9,535 | $76K | 14.1% |
| 6 | $7.99 | 9,535 |
| $76K |
| 14.1% |
| 7 | $7.99 | 10,401 | $83K | 15.3% |
| 8 | $7.99 | 10,401 | $83K | 15.3% |
| Total | $8.05 avg | 67,346 | $542K | 100% |
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |